Redwood Group International (RDWD)
used to be SIVC
4115 Blackhawk Plaza Circle
Danville, CA 94506
Click on filings for most recent information
Cusip number: 78484Q202
Redwood Capital, Inc. assists private Chinese companies in accessing the North American capital markets by utilizing a network of investment banking relationships to achieve reverse merger transactions. For more information, please visit http://www.redwoodcapinc.com.
Redwood Capital team: http://www.redwoodcapinc.com/en/our_team.htm :
Jim Bickel: Chairman and CEO
Charlie Wu: COO and Managing Director
Matthew Totty: Managing Director
Redwood Medical, Inc. assists companies seeking to import and distribute Western medical technologies and products into the China market.
Redwood Group International's wholly-owned portfolio investment, Redwood Capital, Inc., assists private Chinese companies in accessing U.S. capital markets utilizing an existing network of investment banking relationships. Redwood Capital relies on a highly experienced investment and corporate management team focused on the emerging presence of Chinese corporations in the global capital markets.
China's rapid economic growth and increasingly global reach demand large amounts of private capital, and, unfortunately, experience with western investment banking practices is limited in Chinese corporations. Redwood Capital bridges this gap between Chinese capital needs and American public markets and assists Chinese low-tech and high-tech companies who wish to enter the U.S. market with rapid access to public capital markets.
Redwood Capital assists with the preparation of offering materials, public and investor relations, and SEC filings, assisting the client to become eligible for a Nasdaq/NYSE/AMEX listing and underwriting activities in the U.S. markets. In exchange for its involvement in the client's entrance into the U.S. financial markets, Redwood Capital receives a combination of fees and equity in the new U.S. company.
Redwood Capital's completed RTOs
Mar 3, 2009 Boyuan Construction Group inc. has completed the CDN$48.75 million acquisition of SND Energy Ltd. through a reverse-takeover transaction. As a result of the completed acquisition and concurrent financing, Boyuan's common shares and its convertible debentures have received conditional listing approval from the TSX Venture Exchange. *
Of the "798,002 shares received in Boyuan, 287,291 remain restricted from sale due to certain lock-up rules as determined by the Toronto Stock Exchange. The Company received 33,022 shares upon the initial close of the first capital raise it helped to transact, and will receive increments of 49,533 of the total in 6-month intervals beginning September 1, 2009."
These will be sold as market conditions permit in order to fund operations through fiscal year ending June 2010.
Dec. 31, 2007 Energroup Hldg s Corp. (Chuming has completed its reverse merger and is currently trading in the U.S. public markets under the symbol ENHD. Chuming investor presentation link: ** http://www.sec.gov/Archives/edgar/data/766659/000114420408011578/v104808_ex99-1.htm
June 6, 2005 Fushi Copperweld, Inc., has completed its reverse merger and is currently trading in the U.S. public markets under the symbol FSIN. Fushi home page link:
Redwood Capital's completed Equity Offerings:
10/22/09 - S3 Investment Company Announces Completion of USD$10 Million Financing for Redwood Capital Client China Infrastructure Construction Corp ***
May 2011 Mongolian Resource Corporation Ltd (MUB)
RDWD got 1 millin shares of MUB - 10 million dollars raised by MUB, and Bickel is listed on BOD
Summary of Redwood Capital Investment
Equity Position: 100%
Expected Return to S3 Shareholders:
-Value of ongoing 100% equity position in revenue payments back to S3
-Capital appreciation of S3 stock as portfolio value of Redwood Capital increases
4115 Blackhawk Plaza Circle, Ste 100
Danville, CA 94506
Redwood Medical Subsidiary in the China Market:
The first product scheduled to be distributed by the company's Redwood Medical subsidiary is the Piccolo xpress testing device developed and manufactured by Abaxis Inc., a U.S. based medical products company manufacturing point-of-care blood analysis systems. The Piccolo xpress product has received approval from China's State Food and Drug Administration, and Redwood Medical has signed an exclusive long-term agreement to distribute the Piccolo xpress device and its disposable discs throughout China.
S3's Redwood Medical subsidiary was formed to distribute Western medical technologies and products into China, which is experiencing a growing demand for the highest quality medical products and technologies. Redwood Medical staff recently came to the United States to meet with Abaxis, Inc. at their Union City, California headquarters and make further preparations for distribution of the Piccolo xpress product.
"Our relationship with Abaxis dates back several years now, and we are pleased to have our Redwood Medical subsidiary begin the distribution process for the Piccolo xpress," said S3 Chairman and CEO Jim Bickel. "This is a tremendous product that we believe will be very successful in the China market. Having been involved throughout the SFDA approval process in China, we are already familiar with the Piccolo xpress and its capabilities."
Redwood Asia Fund LP.
Redwood owns one small fund with about $50m, it is for the purpose of Pre-IPO private equity investment for qualified companies and part of money can be invested as the listing expenses such as financial advisory, auditor, Sino & foreign legal council.
The private equity fund was formed to facilitate faster capital response to the financing needs of Redwood Capital clients and greater participation in clients' future growth. Richard Chiang, who has extensive experience in corporate finance, is Managing Director of the Redwood Asia Fund LP. Before joining Redwood Asia Fund LP, Mr. Chiang was an Associate Director of Bear, Stearns & Co., Inc., where he managed over $600 million in client assets, a Senior Vice President of Roth Capital Partners LLC, a Vice President of Wedbush Morgan Securities, Inc., an Associate at Lehman Brothers and an Associate Partner at BayPeak LLC, a private equity China financial advisory firm. He has over 15 years experience in areas of investment banking, fund management, corporate finance, sales and trading, venture services, and private wealth management. Mr. Chiang graduated from the University of California at Berkeley, The Walter A. Haas School of Business and the Goldman School of Public Policy with a degree in Business and Public Policy.
Redwood Group International Management:
James Bickel, Chairman, Chief Executive Officer Mr. Bickel has over 40 years experience in sales and senior management positions with manufacturing based companies, serving as the president of Allison Spring and Manufacturing from 1968 to 1973, Bicor Machinery and Manufacturing from 1974 to 1979, and Keel Corporation from 1980 to 1986, all California based manufacturing companies of high tech metal parts and assemblies. From 1986 to 2002, Mr. Bickel served as vice president of Uniglobe USA and president of Uniglobe Midpacific, assisting in building a national travel franchise system with over 900 locations and later built golf retail franchise system. From 2002 to 2003, Mr. Bickel acted as vice president and secretary of World Health and Education Foundation and as vice chairman of MedChannel LLC, a medical device company serving radiology and surgical markets. Mr. Bickel served as Chief Operating Officer and Director of Green Globe International, Inc. from 2005 to 2008, a member of the Board of Directors of Sovereign Exploration Associates International Inc. during 2005 and a member of the Board of Directors of Aero Performance Products during 2007. Mr. Bickel has served on the Board of Directors of CLX Medical, Inc. since 2005. Mr. Bickel has served as Chief Executive Officer and President of S3 Investment Company since January 2006 and Chairman of the Board of Directors since January 2007Karen Riessen, Controller Ms. Riessen brings considerable experience as controller for several venture funded start-up clients. This experience will be invaluable for S3 and its potential subsidiary clients. In her role, she has maintained monthly financial data, payroll and monthly and year-to-date financial statements. She has also prepared budget and cash forecasts, designed and implemented internal controls, software and conversion implementation, and policies and procedures manuals, audit and tax preparation, and maintained corporate documentation necessary for financial audits. Ms Riessen is replacing Ms Mohr as of September 2009. To assist with the transition, Ms.Mohr will continue to work with the company on a consulting basis through the end of the 2009 calendar year.
Gary Nerison, Independent Director
Mr. Nerison is an experienced entrepreneur in commercial real estate and loan brokerage companies. With his rich business commercial real estate background, over the last 36 years, Mr. Nerison has initiated and led to growth several commercial real estate and loan brokerage companies. In 1998, he founded a loan brokerage firm placing venture loans for new business, which he still currently manages. Since 2002, he has been the Co-founder and President of World Health and Education Foundation, a charitable organization. Mr. Nerison attended Augustana College in Sioux Falls, South Dakota with Major in Economics.
Manhong (Mannie) Liu, Independent Director Mannie Liu is the founder, chairman and chief economist of China Ltd., whose operations include venture capital investment advisory services, venture capital investment, consulting services, and educational services. Under Ms. Liu leadership, China has become one of the leading companies in China's venture capital market.
Ms. Liu has a doctoral degree of economics from Cornell University. She served as research faculty of Harvard University from 1993 to 1997 and is currently professor and Ph.D. student mentor of Renmin University of China. She is also Financial Advisor to the Beijing Municipal Government, Director of Boston China Finance Research Center in the U.S., Director of the VC Research Center of Renmin University of China, and Honorary Vice Director of the VC Association of China.
Charlie Wu, Managing Director - China Mr. Charlie Wu, a native to China, has long term management experience and proven success in many ventures. Prior to joining Redwood he was the General Manager of GreCon GmbH, which was a joint venture of our Parent Company, S3 Investments, and a German company where he grew the company successfully for several years. In March 2006, he accepted the position of Managing Director of Redwood China. Mr. Wu has a degree in engineering and vast experience in strategic planning, investment decisions, establishing a business model and enterprise management.
Matthew Totty, Director of Research Mr. Totty has more than 15 years of Wall Street experience in various capacities. He began as a broker and later transitioned into an Analyst and Fund Manager. He was one of the founding members of GunnAllen Financial and while serving as Chief Equity Analyst for that firm was identified as the #1 performing Analyst on Wall Street by the Wall Street Journal. Mr. Totty has served as CEO of many companies and brings extensive public company management and analysis experience to the Redwood team.
Mr. Totty has also been a contributing analyst to William O'Neil & Co.'s Institutional Research Department, publishers of Investor's Business Daily, Zacks Research and First Call earnings estimates. Mr. Totty has been an affiliate of the Market Technicians Assoc. (MTA) and a colleague of the International Federation of Technical Analysts (IFTA). Mr. Totty and his company were also a former member of the Business Council for the United Nations.
Click on Filings tab
317 SW Alder St., 2nd Floor
Portland, OR 97204
Outstanding Shares 3,403,312,815 as of Sept 30, 2010 *
Authorized Shares 4,900,000,000 as of Sept 30, 2010
Number of Shareholders of Record 199 as of Sept 30, 2010
Beneficial Shareholders are unknown
Float 2,172,802,479 as of Sept 30, 2010
There are 200 shareholders of record of common stock
Preferred Stock: As of September 30, 2010
(i) Period ending September 30, 2010
(ii) 15,000,000 shares of Series B Preferred Stock authorized and 25,000,000
shares of Series D Preferred Stock authorized
(iii) 12,000,000 shares of Series B Preferred Stock issued and outstanding and
25,000,000 shares of Series D Preferred Stock issued and outstanding
(iv) No shares of Series B and Series D Preferred Stock in the public float
(v) There are 10 beneficial shareholders of Series B Preferred Stock and 3
beneficial shareholders of Series D Preferred Stock
(vi) There are 10 shareholders of record of Series B Preferred Stock and 3
shareholders of Series D Preferred Stock
Redwood Group International
4115 Blackhawk Plaza Circle, Ste 100
Danville, CA 94506
Public and Investor Relations
Redwood Group International (OTC: RDWD)
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp